MMJ PhytoTech Limited announced important changes to the board and management team of the Company. These changes follow the successful completion of the merger between the Company and MMJ Bioscience Inc. on 27 July 2015 and the strategic positioning of the Company as a fully integrated medical cannabis company with operations spanning the entire medical cannabis value chain across multiple jurisdictions. Boaz Wachtel has tendered his resignation from his position of Executive Director and Head of International Business Development effective 20 August 2015.

In addition, Benad Goldwasser has also stepped down from his position as Executive Director on the board of MMJ PhytoTech but will continue to support the Company through his ongoing role as Chairman of PhytoTech Therapeutics Ltd, the Company's Israeli subsidiary.